Kalmbach Thomas Peter, EVP and CFO of Globe Life Inc. (GL), has been a consistent seller of company stock over the past year, with SEC Form 4 filings showing 39 total transactions—all involving GL—and no open-market purchases. The aggregate value of his sales reached approximately $19.7 million, while his acquisitions were limited to option exercises and equity grants valued at zero, indicating a clear disposition bias rather than accumulation. The most recent cluster of activity occurred on July 30, 2026, when he executed four open-market sales totaling roughly $3.78 million, paired with two option exercises worth about $2.36 million, a pattern that suggests he is monetizing vested awards rather than initiating new positions.
The selling has been steady and substantial throughout 2026. On July 28, he sold shares worth approximately $4.58 million across three transactions, following option exercises valued at $3.18 million. Earlier in May, he completed multiple sales on May 8, May 11, May 19, and May 22, with individual transaction values ranging from $67,212 to $2.13 million, cumulatively exceeding $7.2 million for that month alone. These sales were consistently paired with option exercises of similar magnitude, such as a $1.47 million exercise on May 8 and a $1.97 million exercise on May 11, reinforcing the interpretation that the sales are tied to equity compensation rather than discretionary divestment.
Notably, there are no recent purchases (code "P") in the filing history, and the only non-sale transactions include two grants (code "A") on February 27, 2026, valued at zero, and a tax-withholding event (code "F") on February 25, 2026, worth $553,824. The absence of open-market buying, combined with the regular, sizable sales tied to option exercises, paints a picture of an executive systematically liquidating equity as it vests, with no indication of new capital being deployed into the company’s stock.
AI-assisted summary